Measurement of Fibroid Volume and 2D, 3D US
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02638688 |
Recruitment Status :
Completed
First Posted : December 23, 2015
Last Update Posted : December 23, 2015
|
Sponsor:
Zagazig University
Information provided by (Responsible Party):
Sherin A Shazly, Zagazig University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
Objective: To compare 2-dimensional and 3-dimensional ultrasound measurements with the actual myomas volume after surgical removal, to clinically test the validity and usability of 3D ultrasound technology as opposed to conventional 2D real-time ultrasound and to assess the reliability of different ultrasound methods to measure volume of uterine fibroids.
Condition or disease | Intervention/treatment |
---|---|
Gynecology | Other: ultrasound |
Study Type : | Observational |
Actual Enrollment : | 3 participants |
Observational Model: | Case-Only |
Time Perspective: | Cross-Sectional |
Official Title: | Uterine Fibroid Volume After Myomectomy Compared to Pre-operative Measurement by Two and Three-dimensional Ultrasound |
Study Start Date : | September 2012 |
Actual Primary Completion Date : | June 2015 |
Actual Study Completion Date : | June 2015 |
Group/Cohort | Intervention/treatment |
---|---|
2D ultrasound
2D-US measurements are the most accurate method for measuring fibroid volumes
|
Other: ultrasound |
3D ultrasound
3D-US measurements are the most accurate method for measuring fibroid volumes
|
Other: ultrasound |
postoperative
actual volume using change in water path measurements are the most accurate method for measuring fibroid volumes
|
Other: ultrasound |
Primary Outcome Measures :
- measuring fibroid volumes [ Time Frame: 2012-2015 ]
Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 22 Years to 50 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Study Population
44
Criteria
Inclusion Criteria:
- surgical intervention
Exclusion Criteria:
- unfit for surgery
No Contacts or Locations Provided
Responsible Party: | Sherin A Shazly, Faculty, Zagazig University |
ClinicalTrials.gov Identifier: | NCT02638688 |
Other Study ID Numbers: |
s.shazly 2011 ( Registry Identifier: sherin ) |
First Posted: | December 23, 2015 Key Record Dates |
Last Update Posted: | December 23, 2015 |
Last Verified: | December 2015 |
Additional relevant MeSH terms:
Leiomyoma Neoplasms, Muscle Tissue Neoplasms, Connective and Soft Tissue Neoplasms by Histologic Type Neoplasms |